BRIEF-Editas Medicine Q2 Net Income USD -18.23 Million Vs. IBES Estimate USD -27 Million
Reuters2026/08/05 20:02Aug 05 (Reuters) - Editas Medicine Q2 operating expenses USD 30.444 million.
- Q2 operating income USD -18.554 million
- Q2 basic EPS USD -0.15
- Q2 collaboration and other research and development revenue USD 11.9 million
- Q2 EPS USD -0.15
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Interest rate hike concerns and rising fuel costs push Australia's consumer confidence index close to extreme pessimism
Due to rising fuel costs and concerns that the Reserve Bank of Australia may raise interest rates again, Australian consumer confidence dropped sharply in September, approaching extremely pessimistic levels once more.
Gu Jingci: September 8 Bitcoin/Ethereum Early Trading Strategy with Market Analysis
South Korea's KOSPI index rises 2% intraday, SK Hynix up 3.81%
Crypto prices
More
